LI
TEVA icon

Lafayette Investments’s Teva Pharmaceuticals TEVA Stock Holding History

Lafayette Investments’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-15,700
Closed -$145K – 89
2019
Q2 		$145K Hold
15,700
– – 0.05% 84
2019
Q1 		$246K Hold
15,700
– – 0.09% 76
2018
Q4 		$242K Buy
15,700
+300
+2% +$6.15K 0.1% 77
2018
Q3 		$332K Sell
15,400
-3,050
-17% -$70.8K 0.11% 66
2018
Q2 		$449K Buy
18,450
+600
+3% +$12.2K 0.16% 55
2018
Q1 		$305K Buy
17,850
+1,949
+12% +$38.1K 0.11% 61
2017
Q4 		$301K Buy
15,901
+1,500
+10% +$22.6K 0.11% 62
2017
Q3 		$253K Buy
14,401
+4,400
+44% +$99K 0.09% 66
2017
Q2 		$332K Buy
10,001
+1,400
+16% +$43.3K 0.12% 55
2017
Q1 		$276K Buy
8,601
+950
+12% +$32.4K 0.1% 58
2016
Q4 		$277K Buy
7,651
+2,400
+46% +$95.8K 0.11% 57
2016
Q3 		$242K Buy
5,251
+200
+4% +$10.4K 0.1% 59
2016
Q2 		$254K Hold
5,051
– – 0.1% 58
2016
Q1 		$270K Buy
5,051
+51
+1% +$2.99K 0.11% 58
2015
Q4 		$328K Sell
5,000
-250
-5% -$15.4K 0.14% 55
2015
Q3 		$296K Hold
5,250
– – 0.13% 58
2015
Q2 		$310K Hold
5,250
– – 0.13% 56
2015
Q1 		$327K Hold
5,250
– – 0.14% 57
2014
Q4 		$302K Sell
5,250
-100
-2% -$5.57K 0.13% 58
2014
Q3 		$288K Sell
5,350
-50
-0.9% -$2.65K 0.13% 56
2014
Q2 		$283K Hold
5,400
– – 0.12% 57
2014
Q1 		$285K Sell
5,400
-150
-3% -$6.93K 0.13% 56
2013
Q4 		$222K Buy
+5,550
New +$219K 0.1% 62

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

Lafayette Investments's TEVA Position: Q3 2019 in Review

Lafayette Investments sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 15,700 shares — an estimated $145K sold.

Lafayette Investments first reported a position in TEVA in Q4 2013 and held it in 23 quarters. The position peaked at $449K in Q2 2018. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • Lafayette Investments reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Lafayette Investments sold 15,700 Teva Pharmaceuticals shares in Q3 2019, an estimated $145K.
  • Lafayette Investments first reported a position in Teva Pharmaceuticals in Q4 2013 and held it in 23 quarters.
  • Lafayette Investments's Teva Pharmaceuticals position peaked at $449K in Q2 2018.
  • 427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on Lafayette Investments's 13F filing for Q3 2019, filed 23 Oct 2019.